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Introduction
The commercial cultivation of genetically modified
(GM) crops began in 1996 and has been continuously
expanding ever since, both in industrialised and developing
countries. By 2009 it had reached a global area of 134
million hectares, cultivated by 14 million farmers in 25
countries [James, 2010]. However, acceptance of GM crops
is very heterogeneous. Public opinion in Europe is mostly
seen to be critical (whether because of a lack of perceived
personal benefits, ideologically motivated judgements,
emotional responses or diffuse mistrust of governments and
the media), while most people in the rest of the world are
rather indifferent or (if they are farmers) increasingly in
favour of GM crops [Brook Lyndhurst, 2009].
Differences also exist regarding both the number of GM
crops authorised in different countries and the timing of their
authorisation. The major GM crops – soybeans, maize,
cotton and rapeseed – are also those crops that are the most
heavily traded internationally, providing vital export
revenues for many countries and industries but also
providing a crucial supply of cheap feed and fibres for many
importing countries, including the member states of the
European Union (EU). For climatic and agronomic reasons,
the EU is unable to produce most of the oilseed meal and
other protein-rich feedstuffs required to feed its livestock. In
fact, the EU imports about 80% of its protein needs. Protein-
rich soybean meal, as well as Corn Gluten Feed (CGF) and
Distillers Dried Grain with Solubles (DDGS), are needed by
livestock producers in the EU to achieve a balanced diet for
their animals, especially as far as protein is concerned. There
is no prospect for developing large scale domestic production
of protein rich plants. Even with the increased land sown to
oilseeds for biofuels and stepping up production of protein
crops such as field peas, field beans and sweet lupins to
provide alternatives to soybean, at most they could only
replace between 10–20% of EU imports of soybeans and
soybean meal. Without an adequate supply of these feed
ingredients, the EU’s livestock production will lose
competitiveness and European livestock producers will lose
market share. All EU imports of meat are produced from
animals which may legally be fed with GM plants not yet
authorised in the EU [EC, 2007].
The supply chain of commodity crops (e.g. soya and
maize) is complex. The EU livestock sector uses imported
soybean, soybean meal and maize by-products as animal feed.
Countries exporting these crops are growing both EU-
authorised and non-EU-authorised GM crops, as well as non-
GM crops. The EU decision-making regime for GM products
is relatively slow in comparison with the rest of the world
(asynchronous GM approvals). The supply of non-GM
commodity crops is decreasing as a consequence of an
increase in the volume of GM crops being grown and the
potential for non-EU authorised GM varieties to enter the
non-GM supply chain as adventitious presence is becoming
greater. Combined with the EU’s zero tolerance for
unauthorised GM products, this threatens to create a situation
where traders are reluctant to import any commodity into the
EU (GM or non-GM) that might have a trace level of
unapproved GM material. Organic livestock farmers are
legally required to use non-GM feed. Brazil has been the main
source of non-GM soya, for which a variable price premium
has applied over recent years. There is concern within the EU
feed and food sectors that it is becoming increasingly difficult
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8and costly to maintain a non-GM supply chain, and that it
may become unsustainable at some point in the future.
1. Global status of commercialised GM crops in
2009
Since 1996, when the first GM soybean was harvested,
biotechnology and its adaptations by the food industry have
become one of the most controversial and most disputed topics.
However, the adoption of GM crops is occurring at a rapid pace.
The global area planted toGMcrops in 1996was approximately
1.7 million hectares. GM crop production has increased each
year since then, with an estimated 134 million hectares of GM
crops planted in 2009. The United States is the leading producer
of GM crops accounting for 64 million hectares of the total GM
crop area. Brazil is second, producingGMcrops on 21.4million
hectares. Argentina had 21.3 million hectares of GMO area in
2009. Brazil displaced Argentina to become the second largest
grower of biotech crops in the world (Table 1).
Almost all of the global biotech crop area consists of
soybeans, maize, cotton and canola (Figure 1). In 2009, GM
soybeans accounted for the largest share (52%), followed by
maize (31%), cotton (12%) and canola (5%).
In 2009, GM crops were cultivated on about 14 million
farms in 25 countries. The main producers of GM crops are,
with the exception of the United States and Canada, all
developing countries, i.e., Brazil, Argentina, India, China,
Paraguay and South Africa. Developing countries have
continued to increase their share of global GM crops by
planting 61.5 million hectares, or 46% of the global area of
134 million hectares. In 2009, of the 27 countries in the
European Union, six – Spain, Czech Republic, Portugal,
Romania, Poland and Slovakia – planted Bt maize on 95
thousand hectares compared with a 2008 total of 108
thousand hectares. The decrease was associated with several
factors, including the economic recession, decreased total
plantings of hybrid maize and disincentives for some farmers
due to onerous reporting of intended plantings of Bt maize.
Despite the severe effects of the 2009 economic
recession, record hectarages were reported for all four major
biotech crops occupying 133 million hectares. For the first
time, biotech soybean occupied more than three-quarters of
the 90 million hectares of soybean globally, biotech cotton
almost half of the 33 million hectares of global cotton,
biotech maize over one-quarter of the 158 million hectares of
global maize and biotech canola more than one-fifth of the 31
million hectares of global canola. In terms of the share of
total global plantings to these four crops, biotech traits
accounted for 77% of soybean plantings. For the other three
main crops, the biotech shares in 2009 were 49% for cotton,
26% for maize and 21% for canola (Figure 2). In November
2009, China issued biosafety certificates for biotech varieties
of rice and corn. As rice is the most important food crop
globally, feeding half of humanity, and maize is the most
important feed crop in the world, these biosafety clearances
can have enormous implications for future biotech crop
adoption in China, Asia and the world.
The percent adoption of biotech crops continued to grow
in 2009, for example, for GM maize to 85% in the USA, to
50% inArgentina and to 30% for the summer maize and 53%
for the winter maize in Brazil. The adoption rate of GM
soybean was 98% in Argentina, 91% in the USA and 71% in
Brazil. Percent adoption of GM canola increased to 93% in
Canada. The percentage of exports of transgenic soybean
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Table 1.Area of GM crops by country (2009)
Million hectares
* 8 biotech mega-countries growing at leat 2 million hectaresof GM crops
Source: James [2010]
Country Area GM crops
USA 64.0
Soybean, maize, cotton, canola, squash,
papaya, alfalfa, sugarbeet
Brazil 21.4 Soybean, maize, cotton
Argentina 21.3 Soybean, maize, cotton
India 8.4 Cotton
Canada 8.2 Canola, maize, soybean, sugarbeet
China 3.7 Cotton, tomato, poplar, papaya, sweet pepper
Paraguay 2.2 Soybean
South Africa 2.1 Maize, soybean, cotton
Figure 1. GM crop plantings 2009 by crop
Note: * base area: 133 million hectares; additional GM crop plantings
accounted for 1 million hectares
Source: James [2010]
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Figure 2. Share of GM crops in global plantings of key crops in 2009*
Note: * base area: 133 million hectares; additional GM crop plantings
accounted for 1 million hectares
Source: James [2010]
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9from the USA, Argentina and Brazil is growing from year to
year, in proportion to the rate of adoption of GM soybean by
farmers in the soybean exporting countries. This means that
the animal compound feed industry in the EU is gradually
replacing conventional soybean for its GM counterpart,
without any serious repercussions in the market. In the USA,
the relative share of conventional soybean cultivation
amounts to around 9% of the total soy plantings, while in
Argentina the comparative figure is around 2% for the past
four years. In Brazil there is still room for more transgenic
soybean expansion, as the current relation between GM and
conventional varieties in production amounts to 29% (Table 2).
The economic benefits of genetically modified (GM)
crops are undeniable and with adoption only likely to
increase, and the commercial pipeline suggests that product
quality traits will be increasingly prominent if seed
companies are going to maintain decent margins from the
technology. The claim by GM critics that yield increases over
conventional varieties are not there, thus undermining their
economic benefits, is too simplistic. The economic gains are
not necessarily in direct yield gains, they come from easier
agronomy, better protection from insects and lower input
costs. If you had 30% loss from insects, then you add
protection, there is your gain. The economic bottom line is
undeniable. The economic gains worldwide split almost
equally between developed and developing countries as the
latter have caught up in terms of adoption. But there is a
significant premium in seed prices too [Brookes and Barfoot,
2010].
2. Effects on the feedstuff market in the EU
Maize and maize-byproduct imports
The United States grows about 40% of the maize world
production (around 800 million tonnes a year). Other major
maize producing countries include China, the EU, Brazil,
Mexico, India and Argentina. The United States is not only
the world's top maize producer, but also the top exporter. On
average, about 20 percent of U.S. corn is exported. The
United States, Argentina and Brazil are the the world’s
three largest maize exporters with above 80% share of
world maize trade. The U.S. share of global maize trade is
around 60%, Argentina with a small domestic market is the
world’s second largest maize exporter. In the last several
years, Brazil has targeted the EU’s demand for non-
genetically modified maize. This marketing situation is
assumed to decline as Brazil continues to expand the planting
of GM maize varieties (Table 3).
In fact, the EU has not been able to import maize from
the United States since 1997 because there has not been a
harmonisation of approvals in the EU and the United States.
Other countries, primarily Argentina, have provided a
substitute for the previous exports from the United States.
However, in 2007 there were also substantial problems with
the importation of maize from Argentina for the starch
industry as well as for the feed sector due to a GMO trait
(event GA21 or ”Herculex”) not approved in the EU. Until
this trait was approved in 2008 maize could only have been
exported from Argentina to the EU if the Argentinean
authorities had issued an analysis certificate for each
shipment confirming the absence of GA21. This time
demand for maize in the EU was concentrated on maize
from Brazil, which has intensified the acceleration in
prices on the feedstuff market. The compound feed
producers in the EU had to pay up to 50 €/t more for maize
from Brazil.
The EU used to import significant quantities of maize by-
products from the USA for use as animal protein feed (CGF
and DDGS). However, this trade declined sharply from 2007
because the USA adopted new GM maize crops before they
were cleared for EU import. This was the first example of an
asynchronous GM approval problem for the EU feed and
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Table 2.Adoption rate of GM crops in the leading exporting countries of
maize and soybean (2009)
Notes:* In Brazil the cultivation of GMmaize (MON 810, Liberty Link) was
approved in February 2008 (adoption rate in 2009: summer: 30%; winter:
53%)
Source: USDA [2010], ISAAA [2010]
GM crops Country Adoption rate (%)
Soybean
USA 91
Argentina 98
Brazil 71
Canola Canada 93
Maize
USA 85
Argentina 50
Brazil* 30–53
Table 3. Global maize trade
Million tonnes
*Forecast
Source: USDA [2010] és Toepfer International [2010]
2009/2010 2010/2011*
Global trade 86.0 88.5
Exporters
USA 49.5 50.8
Argentina 12.0 13.0
Brazil 7.5 7.0
Ukraine 5.0 5.0
South Africa 2.5 2.5
Importers
Japan 16.3 16.3
Mexicó 8.0 9.1
South Korea 7.8 8.6
Egypt 5.0 5.4
EU-27 2.5 2.5
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livestock industries. The reduced import of US maize by-
products has been replaced by the use of other feed materials,
at a cost to feed compounders and livestock farmers,
especially in the ruminant sector.
Protein feed imports
Many countries with limited opportunity to expand
oilseed production, such as China and some countries in
South Asia, have invested heavily in crushing capacity in
recent years. As a result, import demand for soybean and
other oilseeds has grown rapidly. China’s expansion of
crushing capacity changes the composition of world trade by
raising global import demand for soybeans rather than for
soybean meal. Argentina, Brazil and the United States
account for 90% of world export of soybean and soybean
meal.
The USA, Brazil and Argentina dominate soybean
cultivation worldwide accounting for 80 to 85% of global
production (250 million tonnes a year). Other significant
producing countries are India, with an output of 7 to 8
million tonnes (3%) and the People’s Republic of China with
16 million tonnes (7%) a year. China is not at all of
significance as an exporting country; it is instead by far the
leading soybean importing country. Imports into China
amounted to 46 million tonnes in 2009/10, or 54% of world
soybean trade. While China has generally no exports, India
exports 3 to 4 million tonnes of soybean meal a year mainly
to the Asian region. Thus, there are no real alternatives to
imports from the three large producing countries.
Soybean global trade is about one third of its total
production. The USA, Brazil and Argentinia contribute
90% of total world soybean exports. Besides China and
India, all the other soybean and soybean meal producing and
exporting countries have for the most part switched the
cultivation of soybeans to the GMO varieties (Table 4).
Soybean meal is the most used vegetable protein feed as
an animal feed ingredient. Soybean meal is considered
premium to other oilmeals due to its high protein content.
The USA, Brazil, Argentina and India are the world’s
major producers and exporters of soy meal. The USA is
the biggest producer but Argentina is the leading exporter
followed by Brazil and the USA. The United States also has
a big domestic demand whereas Argentina has limited local
demand. Soybean meal world production was 161.6 million
tonnes in 2009/2010. Generally, the United States, Argentina
and Brazil contribute 55% of the world soybean meal
production, while China imports soybeans from these
countries in huge and increasing quantities for crushing. In
recent times China has overtaken the U.S. in soybean meal
production.
Soybean meal world trade is around 56 million tonnes,
which is approximately one third of its total production.
Argentina, Brazil and the USA, the world's first, second
and third largest meal exporters, account for 85 to 90% of
total world soybean meal exports. Argentina exports
around 98% of its soybean meal production. No real
alternatives exist to imports from the three large
producing and exporting countries since South East Asian
countries are major markets of Indian soybean meal. India
has a freight advantage overAmerican countries for supply to
Asia (Table 5).
EU-27 imports more than 40% of the soybean meal
available in world market. Though China is a biggest
consumer of soybean meal it does not directly import meal
but beans for crushing. EU-27 is the major destination for
Argentinian and Brazilian soybean meal. The EU imports
soybeans and soybean meal from the three large
soybean producing countries. Of total imports in 2009 the
amount of 12.9 million tonnes of soybeans, 8.9 million
Table 4. Global soybean trade
Million tonnes
*Forecast
Source: USDA [2010] és Toepfer International [2010]
2009/2010 2010/2011*
Global trade 85.4 87.9
Exporters
USA 39.6 36.7
Brazil 28.4 28.9
Argentina 7.5 12.5
Paraguay 5.4 4.8
Importers
China 46.0 49.0
EU-27 13.0 12.6
Japan 3.6 3.6
Mexico 3.5 2.5
Taiwan 2.5 2.3
Table 5. Global soybean meal trade
Million tonnes
*Forecast
Source: USDA [2010] és Toepfer International [2010]
2009/2010 2010/2011*
Global trade 56.0 56.6
Exporters
Argentia 26.0 29.3
Brazil 12.0 11.8
USA 10.2 8.0
India 2.2 3.1
Importers
EU-27 22.5 23.5
Vietnam 2.6 2.7
Indonesia 2.5 2.6
Thailand 2.2 2.2
Japan 1.9 1.9
South Korea 1.9 1.9
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tonnes came from Brazil (69%), 2.2 million tonnes from the
USA (17%) and just 0.1 million tonnes from Argentina
(1%). The remaining 1.7 million tonnes were imported
mainly from other South American countries. Dominating
soybean meal exports into the EU is Argentina and Brazil.
Of total imports of 20.7 million tonnes, 11.2 million tonnes
(54%) came from Argentina and 8.7 million tonnes (42%)
from Brazil. The USA supplied only 0.3 million tonnes
(Table 6).
The world’s largest producer of GM-free soy is still
Brazil. In 2009, 29% of Brazilian soybean production in
2009, or 17 million tonnes, was cultivated as GM-free. Of
this quantity, 9.4 million tonnes, or 16.3% of the Brazilian
soybean harvest, of soybeans certified as GM-free (NON-
GMO-Standard) – i.e. with guaranteed traceability with
respect to origin and purity –were available. The discrepancy
between the quantities of soybean cultivated as GM-free and
the quantities of GM-free certified soya is a result of the fact
that products that have undergone the certification process
are more costly and only if traders are certain that they can
pass on the price surcharge to their customers will they
subject their harvest to such a process. If there is no specific
demand for GM-free soya, then it may simply be mixed with
GM soy and sold as genetically modified. How much GM-
free soy is actually delivered to the EU depends on local
needs, i.e. on European producers of animal feed and food,
on food retailers and on demand from farmers and consumers
[Céleres, 2008].
Besides grain, oilmeals also play an important role for
the feedstuff supply. In total, 56 to 58 million tonnes of
protein-rich feedstuffs are used in the EU in a marketing
year. To a large extent, the oilmeals are not produced in the
EU but rather imported from third countries. Of this, soybean
meal alone accounts 30 million tonnes, or 53%. Around 21
million tonnes are imported directly as soybean meal, while
13 million tonnes come from the processing of soybeans into
soybean meal and soy oil in the EU. The use of rapeseed
meal is also expected to increase further from the current 12
million tonnes. In addition, 7 million tonnes of sunflower
seed meal is used as feed in the EU (Table 7).
Hungary is a large exporter of maize without any imports.
Presently, no GM crops are produced in Hungary due to the
introduction of a moratorium on the production of GMOs in
2005. Most of the protein feed used in Hungary is imported.
Soybean meal accounts for 0.7 million tonnes a year (Table
8). Demand for non-GMO soybean meal is negligable
(petfood producers are the only customers of a small quantity
of non-GMOmeal) since the premium of 50 US$/t is not paid
by the market.
As can be seen from the example of ”Herculex“ (GA21),
delays in the approval process have already had significant
effects on the feedstuff supply in the EU. Due to the delayed
approval process for ”Herculex“, imports into the EU of CGF
and DDGS started to decline dramatically. While 2.6 million
tonnes of CGF and 0.7 million tonnes of DDGS had been
imported in the 2005/2006 marketing year, it was only
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Table 6. EU-27: Imports of soybeans and soybean meal, by country
Source: Eurostat [2010]
Megnevezés
2007
(million
tonnes)
2008
(million
tonnes)
2009
(million
tonnes)
2009
(%)
Soybeans 15.1 14.4 12.9 100
thereof: Brazil 9.5 8.5 8.9 69
USA 3.3 3.7 2.2 17
Argentina 0.3 0.3 0.1 1
Soybean meal 23.6 23.2 20.7 100
thereof: Argentina 14.6 13.2 11.2 54
Brazil 8.5 9.1 8.7 42
USA 0.2 0.5 0.3 1
Table 7. EU-27: Feedstuff balance
Million tonnes
Source: Toepfer International [2010]
Total
domestic use
2008/2009
Total
domestic use
2009/2010
Imports
2008/2009
Imports
2009/2010
Total oilmeals,
grain byproducts,
citrus, beet, pulp
pellets, pulses,
tapioca
82.6 85.0 35.6 34.7
Oilmeals 56.2 57.8 30.4 30.4
Grain byproducts
(CGF, DDGS,
corngermmeal,
wheat bran)
12.6 13.8 0.5 1.0
Citrus/Beet pulp
pellets
5.3 5.9 1.4 1.3
Pulses (peas,
feedbeans, lupins)
2.4 2.4 0.3 0.2
Molassis 5.9 5.2 2.8 1.8
Table 8. Hungary: Imports of feedstuff
Tonnes
Source: Hungarian Central Statistical Office [2010]
2007 2008 2009
Bran, sharps etc from working cereals
and leg plants (2302)
420 1 031 2 964
Residues of starch mfr or sugar mfr or
brewing etc (2303)
22 024 25 785 42 676
Ssoybean oilcake and other solid residue,
wh/not ground (2304)
831 571 796 139 654 648
Oilcake etc nesoi, from veg fats and oils
nesoi (2306)
92 441 54 730 74 408
Cereal groats, meal and pellets (1103) 374 1 463 2 176
Flour and meal of oil seed & olea fruit
(no mustard) (1208)
5 390 4 183 3 979
Rutabagas, hay, clover and other forage
products (1214)
3 743 3 708 796
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around 0.5 million tonnes of CGF and 0.5 million tonnes of
DDGS in 2009/2010. The products imported were those
produced from maize grown in 2006 and exported from the
USA to the EU until December 2007 (Table 8). Anothe
example was the new herbicide-tolerant soybean
(MON89788, known as Roundup Ready 2 or RR2 soybean),
which was submitted in 2006 for approval to United States
and EU authorities. Problems of asynchronous approval in
soybean imports with significant increases in feed
expenditure costs were expected for the case of RR2
soybeans, thus avoiding the expected problem of low-level
presence in soybean imports to the EU RR2 was authorised
by the European Commission rather quickly at the end of
2008 [EC, 2008].
Together with the Corn Refiners Association in the USA,
the exporter and importers created an action plan that
attempted to ensure that no Herculex GMO would be found
in any delivery of CGF and DDGS into the EU. However, in
two thirds of all samples tested, Herculex corn was found.
This confirms the high sensitivity of the specific testing
method (basically a single changed gene in a sample is
sufficient to result in a positive signal) and that in spite of the
greatest possible separation of the flow of goods, absolute
zero tolerance cannot be guaranteed. In addition to CGF
and DDGS, rapeseed meal also could not be imported into
the EU in 2008 because the approval had not yet been
received for a trait that was cultivated in Canada. In the past,
the EU imported up to 0.6 million tonnes of rapeseed meal
from Canada [Toepfer International, 2008].
In the case of CGF and DDGS, it will be possible to once
again import larger volumes in 2010 following the approval of
three maize events by the EU Commission in November 2009.
The volume of imports depends heavily on the competitive
pricing of these commodities. The amount of feedstuff imports
to the EUwill also depend in the future on further developments
in the area of green genetic engineering. In particular this affects
maize and soybean imports from North and South America.
Since 2006, genetically modifiedmaize events have been grown
in the USA and Canada which until November 2009 were not
approved in the EU. Thus importing maize and maize
byproducts (corn gluten and DDG) from the USA was only
possible until this time at high risk. With the approval of three
maize events (MON 89034, MON88017 and MIR604) in
October and November 2009, imports of corn gluten and DDG
once again became possible [Toepfer International, 2010].
However, new events, for example “stacked" event (a
combination of multiple events) will be available in the future
for cultivation that has not yet successfully passed the EU
approval procedure. The rule on complete zero tolerance
continues to apply to suchGMOs that have not yet been fully
approved in the EU so that even the smallest, non-quantifiable
traces of non-approved GM events result in a marketing ban.
That was the case in 2009when traces of the triffid linseed event
were proven to be in Canadian linseed.
Against this backdrop, European associations in the food
and animal feed chain have asked the EU Commission to
come up with a proposal for a technical solution as soon as
possible. Otherwise trade distortions and competitive
disadvantages once again threaten the EU's agricultural and
food industry. In addition the approval procedure, as
originally provided for in the legislation, must be placed on a
purely scientific basis in order to speed up the approval
process and achieve greater harmonisation with approvals in
the export countries. Binding regulations on the existence of
minor traces of genetically modified materials (low-level
presence) are also urgently needed. This is the only way of
sustaining the EU agricultural and food industry in the long
term and of maintaining the highest possible level of
domestic food production.
3. The authorisation process in practice
The problem with GM is the way it has been introduced,
primarily as a way of maintaining the sales of pesticide
companies. In less than three decades, a handful of
multinational corporations have engineered a fast and furious
corporate enclosure of the first link in the food chain. The
concentration of corporate power in commercial seed and
agrochemical production is unprecedented, as is its crossover
with the powerful US-based commodity trading corporations
Cargill, ADM and Bunge. In 2007, intellectual property
rights have been applied to 67% of the global seed market
(Table 9). Three companies – US-based Monsanto, DuPont
and Swiss-headquartered Syngenta – controlled nearly half
of the total global market in proprietary seeds. Just six
companies – the above three plus Bayer, BASF and Dow
AgroSciences – control over two-thirds of the global
agrochemical market [ETC Group, 2008].
Every GMO that is allowed to be placed on the market in
the EU is required to be labelled if it contains more than
0.9% GMO. If it has less than 0.9% GMO, it does not have to
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Table 9.World’s Top 10 seed companies
Source: ETC Group [2008]
Company
2007 seed sales (US$
millions)
% of global proprietary
seed market
1. Monsanto (US) 4,964 23
2. DuPont (US) 3,300 15
3. Syngenta
(Switzerland)
2,018 9
4. Groupe Limagrain
(France)
1,226 6
5. Land O’ Lakes (US) 917 4
6. KWSAG (Germany) 702 3
7. Bayer Crop Science
(Germany)
524 2
8. Sakata (Japan) 396 <2
9. DLF-Trifolium
(Denmark)
391 <2
10. Takii (Japan) 347 <2
Top 10 Total 14,785 67%
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be labelled, provided that this amount
is either adventitious or technically
unavoidable. In the USA, Canada,
Japan and Taiwan, food with a content
of up to 5% of approved GM material
can be classified as “non-GM”;
however, in Australia, New Zealand,
South Africa, Brazil or China, all food
with more than 1% approved GM
material has to be labelled as “GM”
[Ramessar et al., 2008].
Although the approval process for a
GMO is subject to clear rules and
regulations, time and again these rules
and regulations are more or less
overridden. This does not apply to the
scientific risk assessment. Article 18,
Section 1 of Regulation 1829/2003 sti-
pulates that the EFSA (European Food
SafetyAuthority) should attempt to give
its opinion within a period of six months
from receipt of a valid application.
However, the EFSA does at times take
an extremely long time to complete the
risk assessment. There have also been
cases in which delays were due to
incomplete applications received from
the companies. However, to a large
extent it is the EU Member States who
are contributing to the delays in the
approval process. An example of this is
the “Herculex” corn: The Commission
granted the approval for “Herculex”
corn (DAS 59122-7) effective October
24, 2007 two years and nine months
after the application had been filed [DG
AGRI, 2007]. The EU GMO approval
system takes more time than in other
countries (average of over 30 months
compared to 15 months for example in
the USA (Table 10).
The commercialisation of GM
crops is a regulated activity, and
countries have different authorisation
procedures. New GM crops are not
approved simultaneously. This asyn-
chronous approval in combination
with a zero-tolerance policy towards
low-level presence of nationally
unapproved GM material in crop
imports is of growing concern for its
potential economic impact on inter-
national trade. There is an obvious difference between
traces of nationally unapproved GM material due to
asynchronous approval and isolated foreign approval or
due to the accidental presence of research events: in the
former two cases the source of the traces is a GM crop that –
somewhere – presumably has passed some kind of safety
evaluation and has been authorised for commercial use. By
contrast, traces of research events necessarily come from
crops that are not authorised for commercial use anywhere
[Stein and Rodríguez-Cerezo, 2010b]:
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Table 10.Asynchrony of first approvals of GM crops for any use between the United States and the EU
(2009)
Notes: (i) Apart from asynchronous approval (AA) and isolated foreign approval of GM crops between the
United States and the EU, there is also a rising number of GM crops from other countries (China, India) that
contribute to this issue.
(ii) Differences in approval time can also be due to the timing of the submission of the respective dossiers
by the developer.
(iii) Approvals in the EU that are marked with an asterisk (*) have already expired and no renewal has been
sought by the developer.
(iv) In the case of canola, which is of less importance in US agriculture, there are also cases where the event
was approved in the EU first.
Source: Stein and Rodríguez-Cerezo (2009b)
GM crop USA EU Delay (years)
Roundup Ready soy (MON 40-3-2), Monsanto 1994 1996 2
Bollgard cotton (MON531), Monsanto 1995 1997 2
Roundup Ready cotton (MON1445), Monsanto 1995 1997 2
NaturGard KnockOut maize (Bt176), Syngenta 1995 1997* 2
LibertyLink maize (T25), Bayer 1995 1998 3
YieldGard CB maize (MON810), Monsanto 1996 1998 2
Agrisure CB maize (Bt11), Syngenta 1996 1998 2
Agrisure GT maize (GA21), Syngenta 1997 2005 8
LibertyLink canola (T45), Bayer 1998 1998 0
LibertyLink soy (A2704-12), Bayer 1998 2008 10
Roundup Ready canola (GT73), Monsanto 1999 1996 -3
InVigor canola (MS8xRF3), Bayer 1999 1999 0
LibertyLink rice (LLRICE62), Bayer 2000 Assessment Current AA
SeedLink canola (MS1xRF1), Bayer 2002 1996* -6
SeedLink canola (MS1xRF2), Bayer 2002 1997* -5
TOPAS19/2 canola (HCN92), Bayer 2002 1998* -4
Roundup Ready 2 maize (NK603), Monsanto 2000 2005 5
Herculex I maize (1507), Dow/Pioneer 2001 2006 5
Bollgard II cotton (MON15985), Monsanto 2002 2003 1
YieldGard RW maize (MON863), Monsanto 2002 2006 4
LibertyLink cotton (LLCotton25), Bayer 2003 2008 5
Widestrike cotton (210-23x24-236), Dow 2004 Assessment Current AA
Herculex RW maize (59122), Dow/Pioneer 2005 2007 2
Roundup Ready sugar beet (H7-1),
KWS/Monsanto
2005 2007 2
YieldGard VT maize (MON88017), Monsanto 2005 Assessment Current AA
Roundup Ready Flex cotton (MON88913),
Monsanto
2005 Assessment Current AA
Mavera High Value maize (LY038)
Renessen/Monsanto
2006 Assessment Current AA
Roundup Ready 2 soy (MON 89788), Monsanto 2007 2008 1
Agrisure RWmaize (MIR604), Syngenta 2007 Assessment Current AA
Amylase maize (3272), Syngenta 2007 Assessment Current AA
YieldGard VT PRO maize (MON89034),
Monsanto
2008 Assessment Current AA
Optimum GAT maize (98140), Pioneer 2008 Assessment Current AA
Optimum GAT soy (356043), Pioneer 2008 Assessment Current AA
3 events in soy and cotton Submitted Submitted (0)
1 event in potato (BASF’s amflora) Not submitted Approved
Isolated foreign
approvals
7 events in maize, soy, cotton, and alfalfa Submitted Not submitted
>60 events in maize, soy, cotton, canola, potato,
rice, and sugar beet
Approved Not submitted
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1. There can be “asynchronous approval”, i.e., at least
one cultivating country has already authorised a GM
crop while other (importing) countries have not.
2. There can be “isolated foreign approval” (or
“asymmetric approval”), i.e. a cultivating country has
authorised a GM crop but its developer does not seek
approval in (potential or unattractive) importing
countries.
3. There can be “low-level presence” of research events,
i.e., a country has authorised the cultivation of a GM
crop in field trials only but, due to accidental
admixture, traces end up in the commercial crop
supply.
Another question is what level of nationally unapproved
GM material constitutes a "low" level that, depending on the
country, may be tolerated in crop shipments or not. In the
United States, for instance, GM crops as such are not
regulated; it is rather their use (e.g. as food or as pesticide)
that may require their approval. As long as a GM crop is
similar to a conventional crop, no authorisation is needed for
its cultivation or use; only if the crop fulfils, for example, the
function of a pesticide (as insect-resistant or herbicide-
tolerant crops do) does it need to be regulated as such. Hence,
if traces of a GM crop are detected that has not been
submitted to the regulatory agencies, the latter determine on
a case-by-case basis whether the GM crop could pose a risk
and take proportionate measures [USDA, 2007]. In
Switzerland traces of unapproved GM material of up to 0.5
per cent are tolerated in food if the respective GM crop is
already authorised in another country where comparable
procedures are followed or if a danger to human health can
be excluded after an ad-hoc science-based evaluation
[Federal Authorities of the Swiss Confederation, 2008].
And even in the EU the unintentional presence of other
substances is treated differently. For instance, for certain
chemical substances that are present in the environment as
pollutants, levels higher than zero have been set to protect
public health [EC, 2006]. However, there are no tolerance
thresholds for the presence of unapproved GM events, and in
practice low-level presence of unapproved material is
associated to the detection level of laboratory tests. Recently
the introduction of a technical solution for the allowance of
measurement errors has been suggested by Fischer Boel, the
former EU Commissioner for Agriculture to instill
confidence into the detection methods and to avoid false
positives [Fischer Boel, 2009]. At present any traces of
unapproved GM material above the detection level are
considered to represent low-level presence.
Strict regulations in politically powerful or economically
relevant countries may have a detrimental impact on the
development of potentially welfare-enhancing crops. If
developing countries even have to fear the loss of markets for
economically important export crops because of possible but
unavoidable traces of unrelated GM crops, these countries
may become still more hesitant to adopt GM crops for
domestic use that could potentially enhance productivity and
farmers' welfare [Graff et al., 2009].
Low-level presence problems can be expected to
intensify when more new GM crops are commercialised in
the coming years in more countries. By 2015 there could be
over 120 different transgenic events in commercialised GM
crops worldwide – compared with over 30 GM events in
commercially cultivated GM crops in 2008 (Table 11).
Although the commercialisation of the crops shown may be
technically possible by 2015, the practical – or rather
regulatory – feasibility may be more questionable (e.g. for
rice in particular), given that in some of the developer
countries no GM (food) crops have been authorised so far
[Stein and Rodríguez-Cerezo, 2010b].
Another development with GM crops is the emergence of
more players. While currently private companies from the
United States or Europe develop most of the GM events and
crops (which are generally first authorised and cultivated in
the United States), over the next few years more GM crops
will be supplied by private and public entities from Asia in
particular from China and India (Table 12). In the longer
term, even more developing countries may commercialise
GM crops [FAO, 2009]. Hence, while in the past GM crop
adoption spread from North America to other parts of the
world (with asynchrony of approvals following the same
path), in the future the adoption pattern may change
fundamentally, with more new GM crops being adopted first
in Asia and then potentially spreading from there.
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Table 11. Events in commercial GM crops and in pipelines worldwide, by
crop
Notes:* The total number of GM crops by 2015 represents an upper limit,
given that by then some of the current GM crops may have been phased out.
Source: Stein and Rodríguez-Cerezo [2009a]
Crop
Commerci
al in 2008
Commerci
al pipeline
Regulatory
pipeline
Advenced
development
Total by
2015*
Soybeans 1 2 4 10 17
Maize 9 3 5 7 24
Rapeseed 4 0 1 5 10
Cotton 12 1 5 9 27
Rice 0 1 4 10 15
Potatos 0 0 3 5 8
Other crops 7 0 2 14 23
All crops 33 7 24 61 124
Table 12. Events in commercial GM crops and in pipelines worldwide
by region of origin
Source: Stein and Rodríguez-Cerezo [2009a]
Developer
country*
Commercial
in 2008
Commercial
pipeline
Regulatory
pipeline
Advanced
development
Total by
2015
United
States/
Europe
24 7 10 26 67
Asia 9 0 11 34 54
Latin
America
0 0 2 1 3
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This changing pattern, with more new GM crops coming
from Asia, has consequences for the issue of low-level
presence. In Asia, GM crops are usually developed for
domestic consumption and not for export and therefore the
respective events are less likely to be submitted for approval
in the EU or the United States. Hence, incidents due to
isolated foreign approval or asymmetric approval could
become more common (Table 13). However, as has been
seen in the recent cases where traces of GM maize in
soybeans led to the rejection of the soybean shipments, under
certain regulatory settings (in particular zero tolerance
towards low-level presence) the cultivation of one type of
crop may even affect the marketability of other types of
crops. This means that if third countries want to authorise
GM varieties of crops that are welfare-enhancing for their
societies, in future they may also consider the potential
impact of cross low-level presence in different, but export-
relevant, crops. The extent to which this situation shapes the
approval and development of future agbiotech innovations
remains to be seen. Unfortunately, past experience with the
use of GM crops shows that irrational fear of export losses
represents a significant impediment to biosafety
policymaking [Stein and Rodríguez-Cerezo, 2010b].
By 2009, there were already more than 40 individual GM
events that may become potential sources of low-level
presence. And although some of the major exporters of
agricultural commodities – like Argentina and Brazil – so far
have considered trade implications when authorising new
GM crops, it is by no means guaranteed that this situation
will last. Other countries, like China could gain importance
as importers of these commodities (of soybeans in
particular), or the advantages of cultivating certain new GM
crops in exporting countries could simply outweigh the
potential loss of sensitive markets. Moreover, increasing
biotechnology know-how in emerging economies themselves
can strengthen “South-South” technology transfers, which
could boost the acceptance and adoption of GM crops in
cultivating countries. In this case, the number of alternative
suppliers of non-GM crops decreases, thereby making it
more and more difficult to simply redirect trade flows by
matching exporters of GM crops with “easy” importing
countries and letting the remaining exporters supply the more
sensitive markets [Vaidyanathan, 2010].
In the early days there was no concept of using GM to
improve product quality; this would be the way for the future,
including traits that improve water use, nitrogen uptake, salt
and drought tolerance, as well as better nutritional properties
such as Omega-3 or fat profiles. In addition to the increasing
number of new GM events, there is also the tendency to
generate new products by combining different GM traits in
one plant, i.e. through the stacking of already approved GM
events. When individual authorised GM events are “stacked”
by conventional crossing, the resulting new plant may have a
different regulatory status in different countries. For
instance, the EU requires each stacked GM crop to go
through the regulatory system as a new GM crop, irrespective
of whether the parental GM events were already authorised
or not. Given the increase of individual GM events that are to
come to market in the next years, eventually hundreds of
combinations of these events can be quickly developed by
stacking – meaning that the number of GM crops that could
be submitted for approval could increase dramatically.
4. How real is the threat of a major feed supply
problem?
The profitability of livestock production is influenced by
many factors.While its success depends in part on the demand
for the produced products, the operating costs influence the
success or failure of production. Operating costs refer mainly
to feedstuff costs but also to transaction costs such as
environmental regulations, labelling and animal welfare
requirements. In 2008 200,000 tonnes of conventional animal
feed – mainly soy and maize – were refused entry to the EU
when they were found to contain small amounts of GM maize
varieties. Then linseed from Canada was found to contain
traces of a GM variety named CDCTriffid that was withdrawn
from commercial sale in 2001. Following a ban on linseed
more than 100 shipments were rejected, but trade is slowly
resuming. The rejected volume is only a fraction of the 35
million tonnes of feed imported each year. But it leads to
delays to subsequent consignments, higher prices and a
reluctance by importers to risk further shipments.
Although the EU depends much less on imports for maize
than for soybeans, the experience with Bt10 and the Herculex
maize has shown that low-level presence in maize can still
have considerable economic repercussions throughout the
EU’s supply chain. Following the detected presence of GM
maize variety Bt10 (not authorised in the EU) in imports
from the USA in 2005, and more recently the potential for
the accidental presence of the unauthorised GM maize
Herculex, the feed industry has stopped importing CGF and
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Table 13. Asynchronous and isolated foreign approvals as potential sources
for low-level presence
Notes: * Number of individual events authorized for commercial use in at
least one country worldwide, and submitted but not yet authorised in the EU.
# Number of events not submitted for authorisation in the EU but already in
the regulatory pipeline in at least one country worldwide.
Source: Stein and Rodríguez-Cerezo [2009a]
Crop
Asynchronous
approvals*
Isolated foreign
approvals#
Total sources for
low level prsence
Soybeans 2 1 3
Maize 6 5 11
Rapeseed 0 1 1
Cotton 3 9 12
Rice 1 4 5
Potatoes 0 2 2
Other crops 0 8 8
All crops 12 30 42
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DDFS from the USA. Where cargoes have been rejected due
to the presence of unauthorised GM varieties these have been
re-directed to other markets. Alternative cereal proteins have
been sourced but at an additional cost to livestock producers.
Moreover, especially for maize the stacking of events can
quickly generate more crops that are considered new GMOs
under the EU’s regulatory framework.
A possible situation of asynchronous approval of RR2
soybeans was avoided by their approval by the European
Commission before first commercial plantings took place.
Soybean imports are vital for the EU agrifood sector: more
than 90% of the soybeans used in the EU are imported, and
more than 80% of these imports come from only two
suppliers, namely Brazil and the United States. Therefore,
asynchronous approval in soybeans could not only result in
economic losses for traders and users of soybeans, but in
combination with zero tolerance towards traces of
unapproved GMmaterial, it could pose a real threat to the EU
supply of food and feed. However, the approval of the RR2
soybeans has not solved the problem of asynchronous
approval in soybeans in the long run as there are several new
GM soybeans in the regulatory pipeline and much more in
the advanced R&D pipeline worldwide. Future problems due
to low-level presence in soybeans cannot be excluded.
In 2007, the first approvals were granted in the USA for
the planting of the second generation of transgenic
soybean, namely Roundup Ready 2 (RR2). The farmers had
shown a great deal of interest in the new varieties. These
imports were at risk because the three traits had not been
approved in the EU until the end of 2008. Consequently, a
large part of the protein feedstuff needed in the EU would
heve be absent but also the supply of soy oil and lecithin as
raw materials for the food industry would heve been severely
endangered. Significant increases in feed expenditure costs
were expected for soybeans but the problem was solved by
the timely authorisation of RR2 soybeans by the European
Commission [EC, 2008].
With the continued increase in GM soya cultivation in the
main exporting countries (Argentina’s production is already
98% GM, the US’s cultivation is about 91% while that of
Brazil is 71% and rising) and this is being used in large
volumes as a compound feed ingredient in the EU. The EU
feed and food sectors are worried that it will become
impossible to maintain the current non-GM soya supply
chain. The situation is of more immediate concern for parts
of the animal feed industry due to the volume of soybean and
soybean meal imported for feed use. Certified non-GM soya
costs more than GM, with the premium varying according to
the supply and demand situation It has been anywhere from
US$5/tonne to US$80/tonne in recent years.At the beginning
of 2010, the premium was around US$50-60/tonne. Demand
for non-GMO soybeans and maize for human consumption
fell in Japan and South Korea as well where threshold levels
of up to 5% have been set.
The adoption of GM technology by commodity-
exporting countries, particularly in North and South
America, means that imported feed materials will contain an
increasing proportion of GM-derived products. The demand
for non-GM feed has been decreasing with parts of the EU
livestock industry moving away from organic or identity
preserved conventional feed. It was estimated that over 90%
of compound feed fed to livestock in the EU contains one or
more GM events. According to surveys of Toepfer
International around 3 million tonnes of soybean meal are
used that are not subject to required labelling [Toepfer
International, 2008]. Soybean meal not requiring labelling
thus has a share of approx. 8.5% of total soybean meal
consumption in the EU, so that this can still be referred to as
a niche market. This soybean meal is used almost
exclusively in the broiler sector.
There will be sufficient supply to cover the demand for
soybeans not requiring labelling as long as the premium
requested by the Brazilians is paid. A prerequisite for this,
however, is the authorisation without delay of the new traits
of transgenic soybeans in the EU for placing them on the
market and processing them. If a non-EU approved GM feed
crop is being grown in a supplier country at the same time as
non-GM and/or EU-approved GM varieties, the use of strict
segregation and Identity Preservation systems can reduce the
risk of feed supplies being affected by finding non-approved
material, but they cannot eliminate the risk completely.
Economic theory also suggests that changes in price
differentials would militate against the use of non-EU
approved GM soya lines by Brazil and Argentina. Adoption
of non-EU approved varieties would be expected to create
two distinct markets, for EU-approved and non-EU approved
material respectively. As the price gap for soya products
between the EU and the rest of the world widens there would
be a strong incentive not to switch to non-EU approved
crops, and to invest in Identity Preservation systems to enable
EU export sales to continue and to benefit from the much
higher prices for EU-approved varieties. In contrast to the
above it is highly likely that Brazil and Argentina will in
future adopt new types of GM soya before EU clearance is in
place. Since developing countries like China have a big and
increasing demand for soya imports, the EU is no longer such
a crucial market for suppliers, and therefore the EU market
demand may no longer dictate what Brazil and Argentina
choose to produce. Even if it is unlikely that there will be an
asynchronous GM approval problem directly in relation to
soya supplies from Brazil and Argentina there is still a risk
that as soon as a new GM soya variety is used in the USA it
might lead to trace levels being detected in supplies from
other countries, because of the possibility that a bulk cargo
vessel is used to ship material from both North and South
America.
In addition, the EU’s significance in world soybean and
soybean meal trade is declining. Imports of 2009 into the EU
in the amount of around 13 million tonnes of soybeans and
21 million tonnes of soybean meal represent only one fifth of
world trade – a declining trend that is continuing due to
sharply increasing demand from the Asian region, primarily
China. Soybean imports into China in 2009 alone
represented 54% of world trading volume. Biosafety
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certificates for GM rice and maize issued by the Chinese
Ministry of Agriculture in 2009 represents one of the most
high-profile challenges to China's aggressive policy for the
adoption of transgenic crops. Prices will be higher in the
future owing to a growing market for American farmers
selling crops to China, which accepts mixed shipments.
Increasing numbers of GM crop varieties are on the way,
making screening trickier than ever. In addition, livestock
production, especially in Brazil but also in Argentina, is
growing rapidly. Demand for feedstuffs, particularly for
soybean meal, will increase and domestic consumption is
therefore likely to rise. With international demand for meat
growing rapidly at the same time, Brazil and Argentina will
attempt to use all advances in production in order to expand
the production of soybeans and soybean meal corres-
pondingly. This includes the speedy introduction of new
varietes of transgenic soybeans. The supply of non-GM soya
to the EU market could be reduced as exporters switch to
supplying the rapidly increasing demands in the Chinese and
Indian markets.
If low-level presence problems have already occurred in
the past, when worldwide only about 30 events were
marketed, these are not likely to disappear over the next
several years when there may be more than 120 events in the
global market. More and more countries will plant
genetically modified plants regardless of the length of time
necessary for the approval process in the EU. Individual ad-
hoc measures like the quick approval of one new GM crop or
the other will not and cannot address the underlying
structural problem of low-level presence, as has been shown
by the recent cross low-level presence of GM maize in
soybean shipments. Inevitable more trade disruption will
come from the differences in approval processes in the EU
and the rest of the world [Hornby and Felix, 2009].
Strict laws designed to keep the European Union free of
unauthorised GM crops and products are not working, and
are posing problems for the EU's €150 billion livestock
industry (production of animal farming in the EU was worth
nearly €150 billion in 2008). Under Europe's "zero-
tolerance" laws on GM contamination, introduced in 2007,
the presence of even a few seeds of unauthorised GM
material will rule out an entire shipment. Proposed solutions
cover the need to replace the EU’s current zero tolerance
towards traces of EU unapproved GM material by practical
low-level marketing thresholds above the detection limit. A
more pragmatic screening approach is setting a threshold –
say 0.5 per cent – beneath which GM contamination is
tolerated since such "tolerances" operate for other
contaminants, including pesticides and heavy metals. So why
not for GM material, much of which has been cleared for
human consumption elsewhere in the world? Moreover the
need to address the current situation is also highlighted
where the official testing of imports takes place only once the
shipments have already reached the port of destination (thus
increasing the economic risks of the rejection of the
shipment). Other solutions proposed include the streamlining
of the regulatory systems, mutual recognition of risk
assessments of new GM crops and the implementation of
Codex Alimentarius guidelines.
EU livestock farmers are less dependent on CGF and
DDGS feed imports from the USA but much more dependent
on soybean and soybean meal feed imports from Brazil,
Argentina and the USA. These three countries supply about
90% of EU soybean and soymeal imports. Soya is the most
favoured vegetable protein feed because of its nutritional
efficiency and competitive cost. If this supply chain were
disrupted due to asynchronous authorisations it could have
serious adverse effects on the livestock sector (and
potentially on consumer prices). A significant reduction in
EU livestock production could also have a range of
consequential effects on land use and the environment. It is
however difficult to predict these with any certainty or
precision. The precise impact would depend on the extent
and duration of the shortfall in soya imports. If soya imports
were halted from Brazil and Argentina, there might be scope
to secure alternative supplies of soya from non-GM producer
countries like India, but this would not be expected to cover
a significant shortfall in the current supply (total EU imports
of soya commodities in 2009 were 34 million tonnes,
whereas total production in non-GM exporting third
countries was about 25 million tonnes).
There is potential for a shortfall in soya imports to be
replaced in part by imports of alternative protein crops like
oilseed rape from countries such as Russia and the Ukraine,
although this would be of a lower nutritional value involving
higher costs and reduced productive efficiency. There would
be limited scope to replace the use of imported soya by
increasing domestic production of other protein feeds – for
example co-products from bio-fuel production – in order to
reduce the EU feed industry’s dependence on imported soya.
However, the feed industry’s research has shown that EU
protein production could only replace 10-20% of the protein
supplied by imported soya.What is clear is that soya remains
the most important source of protein in animal feed at
present. If soya product imports were halted or reduced soya
feed would have to be replaced by the use of other, less
effective and more costly feed materials. This in turn would
impact negatively on the productive capacity and
profitability of the livestock sector. The pig and poultry
sectors would be affected in particular.
5. General conclusions
Consumer concerns regarding GM tecnology tend to
fluctuate with time and may increase particularly in response
to increased media coverage. There is a legal requirement to
label both GM food and feed ingredients. Consumers
therefore are able to make an informed choice regarding GM
food ingredients (if these are being used). Many consumers
are unaware of the extent to which GM feed is used as there
is no legal requirement to label products from animals fed on
GM feed. Retailers have differing stated policies regarding
the use of the terms ‘GM’, ‘non-GM’ and ‘GM-free’, which
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can lead to confusion for consumers. Regardless of retailers’
policies regarding animal feed for EU livestock, animal
products imported from outside the EU are likely to have
received GM crop varieties that have not been through the
EU approval process in their feed since there is no legislative
requirement in the EU to label products from animals fed
GM feed. Some products from animals (e.g. meat) imported
from third countries, where non-EU authorised GM crops
were fed to livestock would undercut EU producers, thus
distorting competition. Consumers are unable to distinguish
between sources of products from animals and are likely to
be unaware that GM feed is widely used. Country of origin
labelling would not tell consumers if animals have been fed
GM feed. Consumers may feel that they are being misled.
Most people in Europe may be surprised to discover how
far GM has already penetrated the food supply. Every year
millions of tonnes of soya enter the food chain. About 80% of
soya imported into the EU is genetically modified [Céleres,
2008]. The vast majority of this comes from the United States,
Brazil and Argentina and is used as animal feed, although
most people remain unaware. Shipping in GM soya is
perfectly legal so long as the varieties imported are ones that
have been authorised by the EU. With so much imported GM
soya in the system, it seems increasingly unlikely that food on
the shelves in the EU is free of GM. There is just so much GM
coming in, the probability is that, if you tested food from the
supermarket shelf, you would find traces of GM in it.
Costs of maintaining non-GM supply chains are currently
absorbed mainly by farmers and feed compound producers
rather than being passed on to consumers. However, in the
longer term these costs may result in increases in the price of
products from animals (e.g. milk, meat and eggs) for
consumers. The rise of the premium for non-GM feed for
would eventually restrict consumer choice as products from
third countries would be cheaper. The use of non-GM feed by
EU producers could therefore be driven out by market forces.
It may be timely to inform consumers of the issues
surrounding GM and non-GM supply chains so that they
have a clear understanding of current science, the status of
the non-GM market being reliant on only a few exporting
countries, and the steady increase in GM production.
There will always be a niche [market] that wishes to
consume non-transgenic soybean, but today more than three-
quarters of the population in these countries is consuming
GM soybean and have been doing so in a steady form for the
past ten years. People mostly consume soybean in the form
of meat from livestock that has been fed with compound
feed. This consumption has not grown even higher only
because of a trend of stabilisation or slight decline of
compound feed production in the EU, which was
accompanied also by an increase of meat imports from third
countries, including from Brazil.
The EU is dependent for more than 80% on imports of
vegetable proteins for which there are no substitutes in the
short term. GM and non-GM-soya as a source of protein is
imported from the USA, Argentina and Brazil. Demands
from the EU differ to those from third countries with respect
to the GM varieties grown, and which are authorised for
import into the EU. This could potentially cause problems
where low level adventitious presence of non-EU authorised
GM varieties in imports of GM and non-GM feed would
result in the entire consignment being illegal under the EC
regulatory framework. This presence is likely to arise from
material which is being grown as part of field trials. This
could cause supply problems for the animal feed industry,
and ultimately supply of food to consumers.
While the absence of CGF and DDGS could be absorbed
by rapeseed meal, palm kernel meal and grain (at a higher
price, however), soybean meal can only to a very small extent
be substituted by other protein feedstuffs. The availability of
other protein sources on the world market is nowhere near
enough to substitute to an appreciable extent for soybean
meal. This is true for the animal protein feedstuffs, fishmeal
and meat and bone meal, as well as for the alternative plant
protein feedstuffs, such as feed peas, field beans, lupins and
also rapeseed meal. Also from a nutritional perspective,
soybean meal can be substituted only to a small extent
because of the optimal composition of essential amino acids.
Moreover, it cannot be expected that other countries will be
able to provide the substitute for the exports from the South
American countries. First of all, the necessary climatic
conditions for soybeans limit the number of countries where
soybeans can be cultivated. Secondly, it can be assumed that
because of the increasing competition between grain and
oilseeds (especially soybeans) for hectareage worldwide,
soybean acreage will grow only relatively moderately. This
makes it all the more important to achieve higher yields on
existing crop land. This, too, makes it seem improbable that
Brazil and Argentina will make allowances for the EU when
it grants the approvals for the new traits of transgenic
soybeans.
Asynchronous approval of new GM crops across
international jurisdictions is of growing concern due to its
potential impact on global trade. Different countries have
different authorisation procedures and, even if regulatory
dossiers are submitted at the same time, approval is not given
simultaneously (in some cases, delays can even amount to
years). For instance, by mid-2009 over 40 transgenic events
were approved or close to approval elsewhere but not yet
approved – or not even submitted – in the EU.Yet, like some
other jurisdictions, the EU also operates a zero-tolerance
policy to even the smallest traces of nationally unapproved
GM crops (so-called low-level presence). The resultant
rejection of agricultural imports has already caused high
economic losses and threatens to disrupt global agri-food
supply chains.
The risk that feed supplies could be affected by a low-
level presence of non-EU approved GM material could be
resolved if the EU allowed a tolerance for this, rather than
operating a strict zero tolerance as now. The Commission has
undertaken to come forward with a non-legislative technical
solution to address the difficulties created by a strict zero
tolerance policy. To what extent this would be helpful will
depend on the nature of the proposed solution.
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